Donna Carr
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Molecular Medicine top 10%
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 5
- Melanoma and MAPK Pathways 5
- Oncology 5
- Cancer Treatment and Pharmacology 2
- Cancer-related Molecular Pathways 2
- HER2/EGFR in Cancer Research 2
- Co-authors
- Paul T. Kirschmeier (7 shared papers)W. Robert Bishop (6 shared papers)Linda James (6 shared papers)Hena R. Ashar (3 shared papers)Kimberly Gray (3 shared papers)Lydia Armstrong (3 shared papers)Stuart Black (2 shared papers)William T. Windsor (5 shared papers)
- Journals
- Journal of Biological Chemistry (3 papers)Antimicrobial Agents and Chemotherapy (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)SLAS TECHNOLOGY (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Donna Carr
17 papers receiving 957 citations
Peers
Comparison fields: 5 of 70
- Oncology 350
- Molecular Medicine 61
- Molecular Biology 715
- Applied Microbiology and Biotechnology 16
- Cell Biology 113
Countries citing papers authored by Donna Carr
This map shows the geographic impact of Donna Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Carr more than expected).
Fields of papers citing papers by Donna Carr
This network shows the impact of papers produced by Donna Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Carr. The network helps show where Donna Carr may publish in the future.
Co-authors
The 25 scholars most cited alongside Donna Carr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 260 | |
| 2 | 1997 | 166 | |
| 3 | 2009 | 146 | |
| 4 | 1995 | 129 | |
| 5 | 2001 | 92 | |
| 6 | 2018 | 46 | |
| 7 | 2014 | 38 | |
| 8 | 2019 | 35 | |
| 9 | 1993 | 26 | |
| 10 | 2017 | 16 | |
| 11 | 2006 | 13 | |
| 12 | 2000 | 12 | |
| 13 | 2015 | 9 | |
| 14 | 1999 | 8 | |
| 15 | 2018 | 5 | |
| 16 | 2020 | 3 | |
| 17 | 2022 | 1 |
About Donna Carr
Donna Carr is a scholar working on Molecular Biology, Oncology, Pharmacology, Epidemiology and Molecular Medicine, having authored 17 papers that have together received 1.0k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (5 papers), Melanoma and MAPK Pathways (5 papers), Antibiotic Resistance in Bacteria (3 papers), Pneumonia and Respiratory Infections (2 papers), Cancer Treatment and Pharmacology (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Cancer-related Molecular Pathways (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Oncology (350 citations), Molecular Medicine (61 citations), Molecular Biology (715 citations), Applied Microbiology and Biotechnology (16 citations) and Cell Biology (113 citations). Donna Carr has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Paul T. Kirschmeier, W. Robert Bishop, Linda James, Hena R. Ashar, Kimberly Gray, Lydia Armstrong, Stuart Black, William T. Windsor, Richard Bond and Robert Patton. Their work appears in journals such as Journal of Biological Chemistry, Antimicrobial Agents and Chemotherapy, Bioorganic & Medicinal Chemistry Letters, SLAS TECHNOLOGY and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.